Clinical Mass Spectrometry in Heart Disease

Liam Heaney; Toru Suzuki

doi:10.4081/cardiogenetics.2015.5459

You are currently viewing a new version of our website. To view the old version click .

Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Editorial

5 November 2015

Clinical Mass Spectrometry in Heart Disease

and

Department of Cardiovascular Sciences and NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom

Author to whom correspondence should be addressed.

Cardiogenetics2015, 5(1), 5459;https://doi.org/10.4081/cardiogenetics.2015.5459

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The presence of mass spectrometry (MS) in the clinical setting is not a new feature, with the use of gas chromatography-MS (GC-MS) for toxicology assays reported as far back as the 1970s [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

A Post Mortem Assessment of a 25-Year-Old Man with Ascending Aortic Dissection and a Novel MYLK Variant

Persistent Left Superior Vena Cava: An Overlooked Feature of CHARGE Syndrome?